Berkowitz Jeffrey 4
4 · Esperion Therapeutics, Inc. · Filed May 27, 2022
Insider Transaction Report
Form 4
Berkowitz Jeffrey
Director
Transactions
- Award
Stock Option (right to buy)
2022-05-26+20,000→ 20,000 totalExercise: $5.51Exp: 2032-05-26→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The awards vest in full on the earlier of (i) May 26, 2023 and (ii) the Issuer's next annual meeting of stockholders following May 26, 2022.